To characterize the disease-related glycomics using
two complementary approaches: Functional Glycomics
and newly developed, high sensitive and high-through-put
mass spectrometry.
To identify disease related glycomes in blood and
urine that represent potentially useful Glycobiomarkers
for the early diagnosis, monitoring and treatment
of common disease such as cancer, inflammation, life
style related-diseases, neurodegenerative diseases,
and carbohydrate disorder of glycosylation (CDG)
